HMNC BRAIN HEALTH | a disruptive clinical stage biopharma company pioneering precision psychiatry

Um den vollen visuellen und funktionalen Umfang dieser Website genießen zu können, aktivieren sie bitte Javascript in ihrem Browser.

Pipeline

Current status of our programs

Ketabon

Oral prolonged release formulation of ketamine

Nelivabon

Vasopressin V1b antagonist & test

Cortibon

CRHR1 antagonist tildacerfont & test

PTSD Test

Outlicensed

ABCB1 Test

Commercialized in Europe

Innovation

HMNC Brain Health develops game-changing therapies for mental health disorders

Vision &
Mission

Develop personalized precision psychiatry treatments with AI, setting new standards in psychiatric care.

Excellence

HMNC Brain Health uses state-of-the-art scientific methods to develop future oriented therapies for mental health disorders - based on deep insight into the genomics in mental health